Version June 2024
| Evaluation | Possible treatment |
| Confirm that all anesthetic agents have been discontinued (inhalation and intravenous). Assess doses and timing of last administration of all agents. | Continue supportive care (eg, O2 administration, as well as controlled ventilation and/or blood pressure support if necessary). |
| Consider residual effects of opioids, benzodiazepines, sedative-hypnotic agents, inhalation agents, or anticholinergic agents. | Consider reversal medications (eg, naloxone for opioid overdose, flumazenil for benzodiazepine overdose, physostigmine for anticholinergic agent toxicity). |
| Check for residual effects of neuromuscular blocking agents with a peripheral nerve stimulator. | Administer pharmacologic reversal agents (eg, neostigmine [up to 5 mg] with glycopyrrolate [up to 1 mg] or sugammadex 2 mg/kg) if appropriate. |
| Obtain ABG to rule out hypoxemia and/or hypercapnia with CO2 narcosis. | Correct hypoxemia and hypercapnia. |
| Measure temperature to rule out hypothermia or hyperthermia. | Correct hypothermia or hyperthermia. |
| Measure glucose to rule out hypoglycemia or hyperglycemia and electrolytes to rule out severe abnormalities (eg, hyponatremia or hypernatremia). | Correct abnormalities. |
| Perform basic neurologic examination (eg, the Glasgow coma scale or the Face Arm Speech Test [FAST]). | Consult neurology if acute neurologic event is suspected, notify surgeon, continue supportive care (eg, oxygenation, ventilation, maintenance of cerebral perfusion pressure). |
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟
